City of Hope drug discovery 2 (IMAGE)
Caption
BN-CD38 eradicates acute myeloid leukemia (AML) by inducing the expression of its own therapeutic target and by expanding and redirecting autologous T-cells against AML blasts and leukemia stem cells.
Credit
Flavia Pichiorri, Ph.D., M.S., Lab / City of Hope
Usage Restrictions
Please use photo credit
License
Original content